Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancerJ.-Y. Douillard, R. Sidhu, Salvatore Siena et al.|Annals of Oncology|2014Cited by 603
Antibodies against Human Herpesvirus 8 in Black South African Patients with CancerFreddy Sitas, Robin A. Weiss, Henri Carrara et al.|New England Journal of Medicine|1999Cited by 272
Ondansetron Compared with Granisetron in the Prophylaxis of Cisplatin-lnduced Acute Emesis: A Multicentre Double-Blind, Randomised, Parallel-Group StudyPaul Ruff, B. McQuade, W. Paska et al.|Oncology|2009Cited by 123
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine TumoursÉric Raymond, Nicola Fazio, Matthew H. Kulke et al.|Neuroendocrinology|2018Cited by 55
Frequency of S492R Mutations in the Epidermal Growth Factor Receptor: Analysis of Plasma Dna from Metastatic Colorectal Cancer Patients Treated with Panitumumab or Cetuximab MonotherapyKathryn J. Newhall, R. Sidhu, Timothy Price et al.|Annals of Oncology|2014Cited by 23